Volume 8, Number 9—September 2002
Research
Human Metapneumovirus as a Cause of Community-Acquired Respiratory Illness1
Table
Case/sex | Age (yr) | Past medical history | Influenza vaccine | Clinical signs and symptoms (days symptoms persist/total days ill) |
---|---|---|---|---|
F | 46 | None | No | (7/7) febrile respiratory symptoms, sore throat, malaise, and lethargy. Chest clear |
F | 20 | None | No | (2/7) sore throat, unproductive cough, sternal pain, wheeze. Signs: 37.4°C; chest clear |
M | 1 | None | No | (4/7) coughing, vomiting. OE: 37.2°C, chest and abdomen normal |
F | 75 | Mild hypertension | Yes | (4/7) febrile respiratory illness, cough. Signs: 37.4°C, bilateral basal crackles |
F | 57 | COPDb | Yes | (5/7) coryza, sore throat, thick green sputum. Signs: poor air entry and bilateral crackles |
M | 65 | Mild hypertension | No | (3/7) cough, upper respiratory symptoms. Chest clear |
F | 73 | None | Yes | (6/7) cough, green sputum, and dyspnea |
M | 74 | COPDb IHDb | Yes | (5/7) cough, malaise, sputum, breathlessness |
M | 46 | None | No | (6/7) days sore throat, sputum, wheeze, breathlessness Signs: PEFRb 260 mL/min, wheeze |
aAll made a full recovery.
bCOPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease; OE, on examination; PEFR, peak expiratory flow rate.
1 MZ and JS designed the study; DF and MZ organized the sampling. JS performed the polymerase chain reaction analysis and designed the sequencing strategy. IS collected clinical data. All authors contributed to the writing of the manuscript.
Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.